Commentary

A Pox on Both Your Houses: Should the United States Destroy Its Stockpile of Smallpox Virus?


 

The situation: A potential standoff between Russia and the U.S., both of whom have stashed smallpox virus to develop emergency countermeasures in the event of biological warfare.

Photo credit: Flickr user hukuzatuna (Creative Commons)

Variola major, shown here, causes the most common — and deadliest — form of smallpox.

In advance of the World Health Assembly this May, a commentary in a journal called Biosecurity and Bioterrorism (published online ahead of print on January 10, 2011) calls on the United States to get rid of most or all of its stock of smallpox virus.

The author, Jonathan B. Tucker, Ph.D., is a “professor of science and technology for peace and security” at Darmstadt University of Technology in Germany. That’s a title you don’t hear very often.

But Dr. Tucker writes that many public health experts and scientists, especially those in developing countries, would like to destroy any virus stashes, citing the overexaggerated risk of biological warfare and the existence of antiviral drugs that are in development but could be used in a public health emergency under an Emergency Use Authorization (EUA).

Failing an agreement between the U.S. and Russia to clean house and get rid of their smallpox viruses, Dr. Tucker offers some suggestions for compromise, including an agreement by the U.S. and Russia to share their smallpox research with World Health Organization (WHO) member countries and develop a stash of antiviral drugs to be controlled by the WHO for distribution to victims of a smallpox outbreak anywhere in the world. Both countries would then increase their contribution of smallpox vaccines to this WHO reserve.

What do you think? Should we keep some smallpox virus in reserve, or get rid of it?

–Heidi Splete (on twitter @hsplete)

Recommended Reading

CDC Updates Guidelines on STD Treatment
MDedge Internal Medicine
Hib-MenC-TT Vaccine Works When Given With Pneumococcal Vaccines
MDedge Internal Medicine
IDSA Targets MRSA With New Guidelines
MDedge Internal Medicine
Climate Change May Result in More Skin Disease
MDedge Internal Medicine
Age Is Associated With Mortality Risk in ICU Patients With Pneumonia
MDedge Internal Medicine
Infectious Disease Recommendations Largely Based on Low-Quality Evidence
MDedge Internal Medicine
Herpes Zoster Vaccine Found Effective in Real-World Practice
MDedge Internal Medicine
Trials Give Nod to Antibiotics for Children With Certain AOM
MDedge Internal Medicine
Opportunistic Infection Odds Higher With Some Anti-TNF Agents
MDedge Internal Medicine
European Study Estimates H1N1 Vaccine Effectiveness at 72%
MDedge Internal Medicine